| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $54.8B | $55.1B | $54.6B | $54.0B | $51.7B | $12.6B | $11.8B | $10.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $12.9B | $13.1B | $12.6B | $12.0B | $10.5B | $2.5B | $2.0B | $1.4B |
| Net Income | $5.0B | $5.1B | $4.6B | $5.1B | $4.7B | $1.2B | $0.7B | $0.5B |
| EPS (Basic) | $36.90 | $35.53 | $30.54 | $31.30 | $25.34 | $6.33 | $3.36 | $1.69 |
| EPS (Diluted) | $36.21 | $34.97 | $29.99 | $30.74 | $24.47 | $6.05 | $3.28 | $1.67 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $154.2B | $150.0B | $147.2B | $144.5B | $142.5B | $144.2B | $148.2B | $149.1B |
| Current Assets | $5.1B | $4.2B | $4.1B | $4.0B | $3.6B | $3.9B | $6.5B | $3.3B |
| Cash & Equivalents | $0.5B | $0.5B | $0.7B | $0.6B | $0.6B | $1.0B | $3.5B | $1.5B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $13.3B | $13.5B | $13.2B | $12.1B | $12.5B | $9.9B | $12.4B | $9.6B |
| Stockholders' Equity | $16.1B | $15.6B | $11.1B | $9.1B | $14.1B | $23.8B | $31.4B | $40.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $16.1B | $14.4B | $14.4B | $14.9B | $16.2B | $14.6B | $11.7B | $8.0B |
| Investing Cash Flow | $-11.6B | $-10.7B | $-11.1B | $-9.1B | $-7.8B | $-8.2B | $-7.3B | $-11.3B |
| Capital Expenditures | $11.7B | $11.3B | $11.1B | $9.4B | $7.6B | $7.4B | $7.2B | $5.3B |
| Financing Cash Flow | $-4.4B | $-4.0B | $-3.2B | $-5.8B | $-8.9B | $-9.0B | $-1.6B | $4.8B |